Table 3

F values and associated significance from ANOVA testing for effects of dose from the testing phase for groups I and II

Dependent MeasuresGroup I Flumazenil df [1,5]Group II Flumazenil df [2,14]Group II Midazolam df [2,14]
PCAG7.86* 3-a 0.084.66*
BG4.02* 0.726.08*
MBG0.630.320.00
A1.220.720.39
LSD2.040.080.77
Sedative subscale1.601.118.26*
Stimulant subscale1.890.071.38
Strength of drug effect4.78* 1.517.52**
Drug-liking2.790.192.09
Drug-induced high2.260.624.32*
Good effects2.300.541.39
Bad effects1.830.175.06*
Drug-induced anxiety0.900.820.14
Similar to flumazenil9.12** 3.5710.56**
Similar to saline10.9*** 3.3431.52***
Number correct6.05* 0.197.25**
Number completed0.430.509.48**
Similar to novel1.511.88

F values are from tests for linear effects of dose, except where noted. See Table 2 for details on significance levels

  • 3-a Quadratic effect of dose. * p < .05, ** p < .01, and *** p < .001.